BigHat Biosciences

Hiring activelyHealth & bio · BiotechAI-native

Home

bighatbio.com · San Mateo, CA

Source Form DCIK 0001797256as of 2026-11-13

Funding event

The round itself, as filed
Inferred stageSeries C+
Sold of offered$75.1M of $80.0M
Filed2026-10-26
Days since filing18
Exemption claimed
Rule 506(b)
First-ever Form D
No
Date of first sale
2026-07-17
Investors

No investors named: Form D does not list them

Exemption is the box the issuer checked, not our judgement.

Officers on the filing

Names and roles as filed; addresses are never stored
  • Peyton GreensideExecutive Officer · Director
  • Vineeta AgarwalaDirector
  • Robert ChessDirector
  • Francisco GimenezDirector
  • Andrew ConradDirector
Form D item 3. Related-person addresses stay in the raw filing and appear in no export, API or alert.

Health flags

Three flags, each with the raw inputs behind it · as of 2026-11-13
UndersubscribedNot flagged$75.1M of $80.0M sold3.9 months since first sale
Prior raiseNot flaggedRaised $75.1M against a prior $80.0M$80.0M prior raise, filed 2022-10-03
AmendedNot flaggedNo amendmentNo D/A on file

Open roles

On the employer's own careers page · checked 2026-10-30
23

Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.

Roles link to the employer's own page; Noctura shows titles only.

Also raised in Health & bio

Same sector, 28 days to 2026-11-15
OrcosaSeries A · $6.0M of $11.5M · Ewing, NJQuietChronicleBioPre-seed · $250K of $1.0M · Menlo Park, CAQuiet

103 rounds in Health & bio in the 28 days to 2026-11-12, against 122 in the 28 days before.

Every Monday

The week, written up

Start Signals